High #Decipher score defines the subgroup most at risk of metastatic progression among patients with lower grade tumors classified as National Comprehensive Cancer Network (NCCN) high-risk based on elevated PSA level alone. Presented by David Han, MD Columbia Medicine. #AUA24 coverage > bit.ly/3WsjjWL Rashid K. Sayyid

#Decipher ® predicts clinically significant upgrading on final radical prostatectomy pathology. Presentation by John Sheng WashU Urology. #AUA24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3WAdTsu Amer. Urol. Assn. Decipher by Veracyte

#AUA24 Nimrod Barashi, M.D. Variation in PCa Genomic Subtypes Across PI-RADS Scores and Race UroToday.com Decipher by Veracyte

📍n=760, 81% non-AA, 17% AA
📍Decipher: low (53%), interm (18%), high (29%)
📍PI-RADS 3-5 vs 1-2: more luminal proliferating (31% vs 17%, p=0.004) and luminal B (45%…

Integrating both clinicopathologic ( STARCAP) and genomic risk (Decipher by Veracyte) classifiers will be 🔑 for personalizing care for our #ProstateCancer pts

#aua24

Udit Singhal, MD 👏

Mayo Clinic Urology Michigan Urology Amer. Urol. Assn. Prostate Cancer Foundation PCF Science MUSIC Urology Todd 〽️ Morgan, MD

Awesome study led by Udit Singhal, MD and Robert Dess combining STAR-CAP prognostic score with genomic risk using Decipher by Veracyte GRID as well as MUSIC Urology data. Gives a cool picture of how clinical and genomic risk differ and can be additive. #AUA24

Today at #AUA24 , data on Veracyte, Inc.'s #Decipher products will be featured in four posters and presentations. Check out the session times below!

Data on Veracyte, Inc.'s #Decipher products will be featured in 4 posters and presentations at #AUA24 today. Be sure to attend these sessions, if you are here!

Save the date! Veracyte, Inc.'s #DecipherTeam will be at the Urological Society for American Veterans 2024 (USAV) Annual Meeting in San Antonio, TX on May 5. Stop by our booth to discuss how we are changing #ProstateCancer patient care.

We are proud to announce that Veracyte, Inc.'s #Decipher products will be featured in five posters and presentations at #AUA24 today. If you are here, be sure not to miss these sessions.

Join us May 3- 5 in San Antonio, TX, for the American Urological Association's ( #AUA24 ) 2024 Annual Meeting. Visit Veracyte, Inc.'s #DecipherTeam at booth #607 to explore how we can help patients living with #ProstateCancer .

Deciphering #ProstateCancer : How genomic biomarkers are shaping treatment decisions. Paul Nguyen Dana-Farber joins Neil Desai @UTSWNews to discuss the integration of the #Decipher genomic biomarker in #PCa treatment. #WatchNow > bit.ly/482r1Jr Decipher by Veracyte

This month's #EmployeeSpotlight shines on Ted Manongsong, our Clinical Lab Technician II in Histology. Proficient in microtomy, sample capture, and aiding in assay development. Ted's positivity and support for colleagues make him truly stellar! 🌟

Catch us at the University of Maryland, Radiation Oncology Symposium in Baltimore, MD, today! Swing by our booth to speak with our team about how Veracyte, Inc.'s #DecipherProstate can empower your treatment planning with clarity and confidence.

Happy #DNADay ! Celebrating the completion of the Human Genome Project in 2003, a milestone in science. Thanks to projects like Veracyte's #DecipherProstate , utilizing a 22-gene pathway to tailor treatment plans for #ProstateCancer , empowering patients and doctors.

Today, on #WorldLabDay , we celebrate the amazing work and dedication of those working tirelessly in labs worldwide.Thank you for your dedication to driving results, innovation, and improving patient outcomes. Happy World Lab Day! 🌍🔬

Now that Lab Week has come to a close, we bid adieu to a week filled with recognition, appreciation, & celebration of the incredible work done by our lab team!

To our incredible lab team: Thank you for your dedication, your passion, and your unwavering commitment to excellence.

New data in JCO Precision Oncology show that Veracyte's Decipher Prostate Test is a predictor of disease progression among patients undergoing active surveillance. Learn more about the study & how it is an example of the Veracyte Diagnostics Platform in action: investor.veracyte.com/news-releases/…

Today, catch us at the Iowa Urological Society's 2024 Annual Meeting in Des Moines, IA! Drop by our booth to chat with our team about how Veracyte, Inc.'s #DecipherProstate can enhance your treatment planning with clarity and confidence. Don't miss out!

Lab Week festivities have kicked into high gear, and we're thrilled to add a splash of fun and flair to our celebrations with this year's Barbie theme! This Lab Week, we're embracing the iconic Barbie and Ken personas. #LabWeek #ProstateCancer

Join us today in Walnut Creek, CA for the Bass Medical Group Meet & Greet! Visit Veracyte's #DecipherTeam booth to explore how we help patients living with #ProstateCancer .